Trial Profile
Safety and feasibility of adjuvant chemotherapy with S-1 in Japanese breast cancer patients after primary systemic chemotherapy: a feasibility multicenter study
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 27 Mar 2014
Price :
$35
*
At a glance
- Drugs Gimeracil/oteracil/tegafur (Primary)
- Indications Advanced breast cancer; Breast cancer
- Focus Therapeutic Use
- 27 Mar 2014 New trial record